|
Contents
|
|
|
|
Astrocytic
Tumors
|
|
|
|
|
Alba A. Brandes, Linda Nicolardi,
Alicia Tosoni, Marina Gardiman, Paolo Iuzzolino,
Claudio Ghimenton, Michele Reni, Antonino
Rotilio, Guido Sotti and Mario Ermani
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
.JPG)
Abstract
|
.png)
Full
Text | .png)
Reprint
|
|
Marc Frenay,
C Lebrun, D Fontaine, V Bourg, A Ramaioli, PY Marcy, F Peyrade, JF Michiels
First-line chemotherapy in non resectable low-grade
astrocytomas in adults
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
2095
|
|
Medical
Research Council Brain Tumor Working Party.
Randomized trial
of procarbazine, lomustine, and vincristine in the adjuvant treatment of
high-grade astrocytoma: a Medical Research Council trial.
J Clin Oncol 2001 Jan 15;19(2):509-18.
Abstract |
Reprint |
.gif) Related articles
|
|
Prados
MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R,
Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr
A
phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and
vincristine (PCV) with or without BUdR for the treatment of anaplastic
astrocytoma: a preliminary report of RTOG 9404
Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1109-15
|
|
Michael D. Prados, Charles Scott,
Walter J. Curran, Jr, Diana F. Nelson, Steve
Leibel, Simon Kramer
Procarbazine, Lomustine, and Vincristine (PCV) Chemotherapy for Anaplastic
Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group
Protocols Comparing Survival With Carmustine or PCV Adjuvant Chemotherapy
Journal of Clinical Oncology,
Vol 17, No. 11 (November 1), 1999: 3389-3395. (PDF Full Text)
|
|
|
Gliomas
(High-Grade)
|
|
|
|
|
Brada
M, Stenning S, Gabe R, Thompson LC, Levy D, Rampling R, Erridge S, Saran F,
Gattamaneni R, Hopkins K, Beall S, Collins VP, Lee SM
Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent
High-Grade Glioma.
J Clin Oncol. 2010 Sep 20;. [Epub ahead of print]
Abstract
|
Reprint
| Related
articles
|
|
M
Brada,
DG Thomas, NM Bleehen, JT Roberts, F Senanayake, P Abram, PL Lantos, TH Moss, JW
Ironside, JB Whaley, SP Stenning
Medical Research Council (MRC) Randomised Trial of
Adjuvant Chemotherapy in High Grade Glioma (HGG)
ASCO
Proceedings, 1998 Annual Meeting,
Abstract No. 1543
|
|
Chamberlain
MC, Jaeckle KA
Medical
Research Council adjuvant trial in high-grade gliomas.
J Clin Oncol 2001 Oct 1;19(19):3997-9.
Abstract |
Reprint |
Related articles
|
|
Levin
VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK,
Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW
Phase
III randomized study of postradiotherapy chemotherapy with combination
alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas
Clin Cancer Res. 2003
Mar;9(3):981-90 (PDF
Full Text)
|
|
Levin
VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson
CB
Radiation
therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine,
and vincristine for the treatment of anaplastic gliomas
Int J Radiat Oncol Biol Phys 1995 Apr 30;32(1):75-83
|
|
Levin
VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB
Superiority
of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and
vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
Int
J Radiat Oncol Biol Phys 1990 Feb;18(2):321-4
|
|
|
A. Pace, A. Pompili, M.
Maschio, E. Galie', S. Telera, B. Jandolo, E. Occhipinti, C. M. Carapella
PCV and/or TMZ chemotherapy in 255
gliomas. Analysis of the clinical experience from a neuro-oncology
data-base
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1538
|
|
|
Wick
W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC,
Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T,
Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of
Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or
Temozolomide
J Clin Oncol. 2009 Nov 9;. [Epub ahead of print]
Abstract
|
|
|
Glioblastoma
|
|
|
|
Boiardi
A.
PCV chemotherapy for recurrent glioblastoma
multiforme.
Neurology 2001 Jun 26;56(12):1782
Abstract |
Reprint |
Related articles
|
|
|
Alba A. Brandes, Mario Ermani, Umberto Basso,
Myriam K. Paris, Franco Lumachi, Franco Berti,
Pietro Amistà, Marina Gardiman, Paolo Iuzzolino,
Sergio Turazzi, Silvio Monfardini
Temozolomide in Patients with Glioblastoma at Second Relapse after First Line
Nitrosourea-Procarbazine Failure: A Phase II Study
Oncology,
Vol. 63, No. 1,
38-41, August 2002
Abstract
|
|
Kappelle
AC, Postma TJ, Taphoorn MJ, Groeneveld GJ, van den Bent MJ, van Groeningen
CJ, Zonnenberg BA, Sneeuw KC, Heimans JJ.
PCV
chemotherapy for recurrent glioblastoma multiforme.
Neurology 2001 Jan 9;56(1):118-20.
Abstract |
Reprint |
Related articles
|
|
Levin
VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds
N, Woo S, Rodriguez L, et al
Phase
II study of accelerated fractionation radiation therapy with carboplatin
followed by vincristine chemotherapy for the treatment of glioblastoma
multiforme
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):357-64
|
|
Nieder C.
Treatment of newly diagnosed glioblastoma
multiforme.
J Clin Oncol. 2002 Jul 15;20(14):3179-80; author reply 3181-2.
Abstract |
Reprint |
Related articles
|
|
|
Schmidt F, Fischer J,
Herrlinger U, Dietz K, Dichgans J, Weller M.
PCV
chemotherapy for recurrent
glioblastoma.
Neurology. 2006
Feb 28;66(4):587-9.
Abstract |
Full text
|
Related articles
|
|
R.
Soffietti, A. Costanza, E. Laguzzi, M. Nobile, R. Rudà;
A phase II study of first-line
temozolomide and second-line PCV in recurrent/progressive malignant
gliomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1574
|
|
